Back to search

Japan· JP-3131401A2010

リボフラビンリン酸エステルナトリウム

A riboflavin (vit b2) product containing リボフラビンリン酸エステルナトリウム, registered in Japan, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.

On Japan’s NHI price listATC A11HA04

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedリボフラビンリン酸エステルナトリウムATCA11HA04REGISTER NO.JP-3131401A2010PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Riboflavin (vit b2) is registered in 5 of 19 countries.

Countries holding a registration under ATC A11HA04 (riboflavin (vit b2)), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 4 of them publish a price we can compare per daily dose

Riboflavin (vit b2) · ATC A11HA04

5 / 19 countries

  • Finlandprice
  • Japan
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
リボフラビンリン酸エステルナトリウム
Manufacturer
—
Country
Japan (JP)
ATC code
A11HA04
ATC class
Riboflavin (vit B2)
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Riboflavin (vit b2) in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All riboflavin (vit b2) products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Germany · Vitamin B2 Axicur®
  • Poland · Vitaminum B2

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/af37d5db-1efc-466a-a1ca-d91d823e3bb6
GET /v1/drugs/af37d5db-1efc-466a-a1ca-d91d823e3bb6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "5mg1管",
  "marks": "局",
  "source": "mhlw",
  "remarks": null,
  "yj_code": "3131401A2010",
  "category": "注射薬",
  "price_yen": null,
  "generic_name": "リボフラビンリン酸エステルナトリウム",
  "product_name_jp": null,
  "therapeutic_class": "3131",
  "transitional_expiry": null
}

See everything about riboflavin (vit b2).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.